patrick.net
An Antidote to Corporate Media
1,263,346 comments by 15,096 users - anon5525, Blue, DOGEWontAmountToShit, Searcher46 online now
MIT Engineers Develop RNA Vaccine for Mice
invite response
2016 Jul 4, 6:08pm 1,426 views 3 comments
Comments 1 - 3 of 3 Search these comments
1
curious2
2016 Jul 4, 7:24pm
curious2
2016 Jul 4, 7:24pm
DieBankOfAmericaPhukkingDie says
contests?
So far, it's only for mice, but there's no telling what those rodents might do with this new technology.
2
NoYes
2016 Jul 4, 9:46pm
Maybe it will cure gun violence and extremism and illegial anti American Kenya politicians
3
curious2
2016 Jul 5, 2:01am
curious2
2016 Jul 5, 2:01am
BTW, Monday's MIT multi-purpose vaccine story follows a 2011 MIT design of a multi-purpose "drug that can identify cells that have been infected by any type of virus, then kill those cells to terminate the infection." That research has continued elsewhere, including a 2015 crowdfunding campaign at IndieGoGo; the IndieGoGo campaign closed six days ago.
"MIT engineers have developed a new type of easily customizable vaccine that can be manufactured in one week, allowing it to be rapidly deployed in response to disease outbreaks. So far, they have designed vaccines against Ebola, H1N1 influenza, and Toxoplasma gondii (a relative of the parasite that causes malaria), which were 100 percent effective in tests in mice.
The vaccine consists of strands of genetic material known as messenger RNA, which can be designed to code for any viral, bacterial, or parasitic protein. These molecules are then packaged into a molecule that delivers the RNA into cells, where it is translated into proteins that provoke an immune response from the host.
In addition to targeting infectious diseases, the researchers are using this approach to create cancer vaccines that would teach the immune system to recognize and destroy tumors.
"This nanoformulation approach allows us to make vaccines against new diseases in only seven days, allowing the potential to deal with sudden outbreaks or make rapid modifications and improvements," says Daniel Anderson, an associate professor in MIT's Department of Chemical Engineering and a member of MIT's Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science (IMES).
#scitech #health